Registration

BROWNSTEIN HYATT FARBER SCHRECK, LLP for KYVERNA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Outreach regarding cell therapies for autoimmune diseases.

LobbyistCovered position, as disclosed
EMILY FELDER New Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
STEPHEN HOLLAND New Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader
LAUREN ALEXANDRA MISH New Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs
ADAM STEINMETZ New Policy Advisor - Committee on the Budget, United States House of Representatives

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.